Long-term Outcomes of Neoadjuvant Chemotherapy With Docetaxel, Cisplatin and S-1 for Stage III Gastric Cancer
Anticancer Research · 2023
DOI: 10.21873/anticanres.16453 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, 2023. Verfasst von Kohei Kasahara und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Gastroenterological Center, Yokohama City University, Yokohama, Japan. Hauptthemen laut MEDLINE: Stomach Neoplasms.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgery, Gastroenterological Center, Yokohama City University, Yokohama, Japan.
- Department of Surgery, Gastroenterological Center, Yokohama City University, Yokohama, Japan; s0714@med.yokohama-cu.ac.jp.
- Department of Surgery, Yokohama Municipal Hospital, Yokohama, Japan.
- Department of Gastroenterological Surgery, Yokohama City University, Graduate School of Medicine, Yokohama, Japan.
Zitieren
APA
Kasahara, K., Kunisaki, C., Sato, S., Kondo, H., Takahashi, M., Tamura, Y., Tsuchiya, N., Tanaka, Y., Sato, K., Kimura, J., Kosaka, T., Ono, H., Makino, H., Akiyama, H., & Endo, I. (2023). Long-term Outcomes of Neoadjuvant Chemotherapy With Docetaxel, Cisplatin and S-1 for Stage III Gastric Cancer. Anticancer Research. https://doi.org/10.21873/anticanres.16453
Vancouver
Kasahara K, Kunisaki C, Sato S, Kondo H, Takahashi M, Tamura Y, et al. Long-term Outcomes of Neoadjuvant Chemotherapy With Docetaxel, Cisplatin and S-1 for Stage III Gastric Cancer. Anticancer Research. 2023. doi:10.21873/anticanres.16453
BibTeX
@article{Kasahara2023,
author = {Kasahara, Kohei and Kunisaki, Chikara and Sato, Sho and Kondo, Hiroki and Takahashi, Masazumi and Tamura, Yuko and Tsuchiya, Nobuhiro and Tanaka, Yusaku and Sato, Kei and Kimura, Jun and Kosaka, Takashi and Ono, Hidetaka and Makino, Hirochika and Akiyama, Hirotoshi and Endo, Itaru},
title = {Long-term Outcomes of Neoadjuvant Chemotherapy With Docetaxel, Cisplatin and S-1 for Stage III Gastric Cancer},
journal = {Anticancer Research},
year = {2023},
doi = {10.21873/anticanres.16453}
}
EUVIMED